Skip to content

Innoviva, Inc. INVA Accounts Receivable

Accounts Receivable at other companies

Pfizer logo
PfizerPFE
$12.59B+6.2%
Merck & Co. logo
Merck & Co.MRK
$12.21B+13.2%
AbbVie logo
AbbVieABBV
$12.48B0.0%
Insmed logo
InsmedINSM
$178.56M+274%
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
$53.38M+38.7%
Alkermes logo
AlkermesALKS
$407.63M+27.9%

Other financials

Income statement

See full
Revenue$98.0M+10.6%
Gross profit$75.8M+3.4%
Operating income$38.2M-7.9%
Net income$186.6M+501%
EPS (diluted)$2.22+400%

Balance sheet

See full
Cash & equivalents$603.1M+89.0%
Total debt$269.4M-40.3%
Total equity$1.3B
Total assets$1.8B+46.4%

Cash flow

See full
Operating cash flow$35.3M-27.4%
CapEx$492.0K
Free cash flow$34.8M-28.4%

Valuation

See full
Market cap$1.74B+51.8%
Enterprise value$1.41B+9.7%
P/E3.5×
P/S4.2×+1.0×

Profitability

See full
Gross margin73.7%-9.9pp
Operating margin38.1%-11.2pp
Net margin119.9%+107pp
FCF margin54.1%+5.3pp

Returns & leverage

See full
Return on equity29.1%
Debt / equity0.2×
Current ratio21.1×+18.7×

Where this comes from

Reported directly by Innoviva, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AccountsReceivableNet.

The official record: Innoviva, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Innoviva, Inc.'s accounts receivable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Innoviva, Inc.'s accounts receivable?
Innoviva, Inc. (INVA) reported accounts receivable of $34.01M in Q1 2026.
How has Innoviva, Inc.'s accounts receivable changed year-over-year?
Innoviva, Inc.'s accounts receivable increased by 104.0% year-over-year, from $16.67M to $34.01M.
What is the long-term trend for Innoviva, Inc.'s accounts receivable?
Over 3 years (2022 to 2025), Innoviva, Inc.'s accounts receivable has grown at a 85.3% compound annual growth rate (CAGR), from $16.14M to $102.73M.
What does accounts receivable mean?
Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.